Corteria Pharmaceuticals
About:
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Website: https://www.corteriapharma.com/
Top Investors: OrbiMed, Jeito Capital, Invivo Capital Partners, Omnes Capital, Kurma Partners
Description:
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Total Funding Amount:
77M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2021-01-01
Founders:
Marie-Laure Ozoux, Philip Janiak
Number of Employees:
1-10
Last Funding Date:
2023-09-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai